glp-1 osteoporosis Positive impact of GIP, and GLP-2 on bone metabolism. GIP exerts GLP-1s and bone loss!
Description
Acute gallstone disease was a medical event of special interest
This article focuses on the basic mechanisms and actions of selected gut hormones/dual-agonists [glucagon-like-peptide (GLP-1), glucose-dependent insulinotropic peptide (GIP), and glucagon] and summarize the outcomes of trials evaluating these incretin agonists [2]
A consultation is essential to assess needs accurately and design a phased treatment plan aligned with long-term goals
To report SUSPECTED ADVERSE REACTIONS, contact Novo Nordisk Inc
